Navigation Links
Queensland businessman is 'one in a million'
Date:2/6/2008

A retiring Queensland businessman has given the 18,700 Australians diagnosed with prostate cancer each year hope for a new treatment by donating $1 million to a Brisbane research project .

The money was donated to the Mater Medical Research Institute (MMRI), where researchers are trialling a world-first therapeutic vaccine which aims to stimulate the immune system to fight prostate cancer.

Professor Hart, Director of the MMRI, said the donation could potentially change the lives of the one in nine Australian men who will be diagnosed with this disease in their lifetime.

The body contains specialised white blood cells, called dendritic cells (DC), which initiate an immune response, Professor Hart said.

These cells direct the bodys fight against invaders like bacteria or foreign bodies but they dont always work effectively against cancer. Our work aims to trigger the immune system to kick in and destroy the prostate cancer and has the potential to revolutionise the treatment of other cancers down the track.

Prof Hart said on average research institutes only received around twenty per cent of the funding they applied for from the Federal Government.

We rely more heavily on donations and corporate support to help progress our research than many people realise and this donation will make a huge difference by enabling us to finish this phase of the trial and fast-track future trials.

Gold Coast based engineer Vince Rehbein made the $1 million donation.

Its frightening to think that 32 men are diagnosed with prostate cancer every single day in Australia, Mr Rehbein said.

I would like to see the awareness of prostate cancer, and the wonderful work thats being done by Professor Hart and his team at the MMRI, significantly increased within our community.

The trial was kick-started with a $1 million donation by Brisbane businessman, Bill Siganto in 2003.

Bills donation back in 2003 was a catalyst for me, said Mr Rehbein.

I always thought that I would do the same thing if I ever had any extra money. Today Im making that dream a reality and hopefully I will inspire other people to do the same thing.

Prostate cancer is the most common cancer in Australian males (after non-melanoma skin cancer) and more than 3,000 men die of prostate cancer in Australia each year.

Twelve patients will be involved in the Phase 1 clinical trial at the MMRI, which is designed to test the safety of the vaccine.


'/>"/>

Contact: Marnie Nichols
mnichols@mmri.mater.org.au
61-731-632-433
Research Australia
Source:Eurekalert

Related medicine news :

1. Fluoridated water for Queensland ... at last
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
4. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
5. 1.5 million children could be saved
6. The Philadelphia Walk Now for Autism Expected to Draw 10,000 Walkers and Raise $1 Million to Help Find Answers About the Nations Fastest-Growing Developmental Disorder
7. UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria
8. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
9. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
10. £5 million investment in personalized medicines to cut patient deaths
11. Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... NJ (PRWEB) , ... October 13, 2017 , ... Global ... at scenic Alexandria Park in Milford, NJ. This free event, sponsored by Global ... physical activity. The fun run is geared towards children of all ages; it ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the ... published author, William Nowers. Captain Nowers and his wife, Millie, have six children, ... in the Navy. Following his career as a naval aviator and carrier pilot, ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
(Date:10/12/2017)... ... , ... HMP , a leader in healthcare events and education, today announced ... Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie ... competition recognizes editorial and design excellence across a range of sectors. This year’s program ...
(Date:10/12/2017)... ... 12, 2017 , ... In the United States, single-family home ... states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the average is ... low property-tax rates, which contributes to the relatively lower cost of living in ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... Oct. 4, 2017  According to the Centers for Disease Control and ... October . PhysicianOne Urgent Care is helping communities across Massachusetts ... , by offering no-cost* flu shots through the end of the ... certain health insurance regulations. ... time to get a flu shot is by the end of October, ...
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
(Date:9/28/2017)... -- Cohen Veterans Bioscience and Early Signal Foundation announce ... home sensors for real-time monitoring of patients with trauma-related ... organization focused on disruptive health solutions for rare disorders ... to record and integrate behavioral, cognitive, physiological and contextual ... ...
Breaking Medicine Technology: